Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:1015-1021
Published online before print August 11, 2003, doi: 10.1161/01.CIR.0000085211.97972.2C
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/8/1015    most recent
01.CIR.0000085211.97972.2Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haider, A.
Right arrow Articles by Ferreri, N. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haider, A.
Right arrow Articles by Ferreri, N. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Growth factors/cytokines
Right arrow Resource utilization
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2003;108:1015.)
© 2003 American Heart Association, Inc.


Basic Science Reports

Dual Functionality of Cyclooxygenase-2 as a Regulator of Tumor Necrosis Factor–Mediated G1 Shortening and Nitric Oxide–Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation

Asifa Haider, PhD; Irene Lee, MD; Jerzy Grabarek, MD, PhD; Zbigniew Darzynkiewicz, MD, PhD; Nicholas R. Ferreri, PhD

From the Department of Pharmacology, New York Medical College, Valhalla, NY.

Correspondence to Dr Nicholas R. Ferreri, New York Medical College, Department of Pharmacology, Valhalla, NY 10595. E-mail nick_ferreri{at}nymc.edu

Received November 11, 2002; revision received April 22, 2003; accepted May 5, 2003.

Background— Cyclooxygenase (COX)-2 contributes to vascular smooth muscle cell (VSMC) proliferation induced by tumor necrosis factor (TNF) and angiotensin II. The present study demonstrates, however, that depending on prevailing conditions, COX-2–derived prostanoids may also inhibit VSMC proliferation.

Methods and Results— TNF-{alpha} stimulated proliferation of VSMCs by shortening the G1 phase of the cell cycle. This effect was abolished by NS-398, a selective COX-2 inhibitor. Addition of TNF did not affect the protein-to-DNA ratio, measured by flow cytometry, suggesting that TNF does not induce VSMC hypertrophy. Inhibition of nitric oxide synthase (NOS) activity attenuated TNF-mediated increases in prostaglandin (PG) I2 synthesis, whereas thromboxane (TX) A2 production and COX-2 protein expression were unaffected. Moreover, inhibition of NOS activity increased TNF-mediated proliferation by {approx}23%. Thus, NO preferentially stimulates PGI2 production, suggesting that production of NO by VSMCs challenged with TNF limits the ability of the cytokine to increase proliferation. NO donors increased COX-2 protein expression and PGI2 synthesis, had no effect on TXA2 production, and decreased cell numbers by 50%, indicating that expression of COX-2 per se might not be sufficient to support proliferation. The effects of NO donors were prevented when COX-2 activity was inhibited with NS-398.

Conclusions— The COX-2–dependent proliferative response of VSMCs to TNF was modulated in an NO-dependent manner, and PGI2 derived from COX-2 might contribute to the antiproliferative effect of NO donors.


Key Words: prostaglandins • muscle, smooth • nitric oxide • thromboxane




This article has been cited by other articles:


Home page
EndocrinologyHome page
J. Kawagoe, M. Ohmichi, S. Tsutsumi, T. Ohta, K. Takahashi, and H. Kurachi
Mechanism of the Divergent Effects of Estrogen on the Cell Proliferation of Human Umbilical Endothelial Versus Aortic Smooth Muscle Cells
Endocrinology, December 1, 2007; 148(12): 6092 - 6099.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Li, Y.-H. Song, J. Mohler, and P. Delafontaine
ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2116 - H2123.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. M. Antman, D. DeMets, and J. Loscalzo
Cyclooxygenase Inhibition and Cardiovascular Risk
Circulation, August 2, 2005; 112(5): 759 - 770.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J.-S. Huang, L.-Y. Chuang, J.-Y. Guh, C.-J. Chen, Y.-L. Yang, T.-A. Chiang, M.-Y. Hung, and T.-N. Liao
Effect of Nitric Oxide-cGMP-Dependent Protein Kinase Activation on Advanced Glycation End-Product-Induced Proliferation in Renal Fibroblasts
J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2318 - 2329.
[Abstract] [Full Text] [PDF]